Planta Med 2007; 73(12): 1322-1326
DOI: 10.1055/s-2007-990219
Biochemistry and Molecular Biology
Original Paper
© Georg Thieme Verlag KG Stuttgart · New York

Discriminating between Achyranthis Bidentatae Radix and Cyathulae Radix in Chinese Medicine Preparations by Nested PCR and DNA Sequencing Methods

Kang-Tsu Lu1 , Han-Yun Cheng1 , Chi-Fang Lo1 , Hsien-Chang Chang1 , Jer-Huei Lin1
  • 1Division of Pharmacognosy, Bureau of Food and Drug Analysis, Department of Health, Executive Yuan, Taipei, Taiwan, ROC
Further Information

Publication History

Received: March 7, 2007 Revised: July 19, 2007

Accepted: August 20, 2007

Publication Date:
24 September 2007 (online)

Abstract

The widely used Achyranthis Bidentatae Radix (Niu Xi) in Chinese medicine preparation is easily misused and confused with Cyathulae Radix (Chuan Niu Xi). Taiwan authority has ruled that Achyranthis Bidentatae Radix and Cyathulae Radix should be individually entered in the given preparations. In this study, with the internal transcribed spacer (ITS) as a DNA marker, nested PCR and DNA sequencing were used to distinguish the two herbs in preparations. Authentic Achyranthis Bidentatae Radix and Cyathulae Radix were collected from the original country, mainland China, and twenty two samples of Chinese medicine preparations labeled with Niu Xi as the ingredient were purchased locally. The total DNA of all samples were extracted by organic solution and purified using a kit. For a standard, ITS regions of authentic Achyranthis Bidentatae Radix and Cyathulae Radix were amplified with PCR and analyzed by an auto-sequencer. The ITS regions of preparation samples of DNA were amplified by nested PCR and the data of sequences received from an auto-sequencer. We compared the ITS sequences of preparation samples with the sequences of a standard and Genbank database to check which Achyranthis Bidentatae Radix or Cyathulae Radix is in the preparation samples. The results showed that only one sample contained Achyranthis Bidentatae Radix and the others contained Cyathulae Radix. The Cyathulae Radix components in four preparation samples do not fit into Taiwan authority rules. And our method can be applied for the differentiation of Achyranthis Bidentatae Radix and Cyathulae Radix in Chinese medicine preparations.

References

  • 1 Chang Y S. Evaluation of the homonymic Chinese crude drug species in Taiwan. Taipei; International Symposium on Chinese Herbs 1997.
  • 2 Li J X, Hareyama T, Tezuka Y, Zhang Y, Miyahara T, Kadota S. Five new oleanolic acid glycosides from Achyranthes bidentata with inhibitory activity on osteoclast formation.  Planta Med. 2005;  71 673-9.
  • 3 Lu T, Mao C, Zhang L, Xu W. The research on analgestic and anti-inflammatory action of different processed products of Achyranthes bidentata .  Zhong Yao Cai. 1997;  20 507-9.
  • 4 Han S B, Lee C W, Yoon Y D, Lee J H, Kang J S, Lee K H. et al . Prevention of arthritic inflammation using an oriental herbal combination BDX-1 isolated from Achyranthes bidentata and Atractylodes japonica .  Arch Pharm Res. 2005;  28 902-8.
  • 5 Tian G Y, Li S T, Song M L, Zheng M S, Li W. Synthesis of Achyranthes bidentata polysaccharide sulfate and its antivirus activity.  Yao Xue Xue Bao. 1995;  30 107-11.
  • 6 Li Z K, Li D D. The immunomodulatory effect of Achyranthes bidentata polysaccharides.  Yao Xue Xue Bao. 1997;  32 881-7.
  • 7 Yu S, Zhang Y. Effect of Achyranthes bidentata polysaccharides (ABP) on antitumor activity and immune function of S180-bearing mice.  Zhonghua Zhong Liu Za Zhi. 1995;  17 275-8.
  • 8 Xiang D B, Li X Y. Antitumor activity and immuno-potentiating actions of Achyranthes bidentata polysaccharides.  Zhongguo Yao Li Xue Bao. 1993;  14 556-61.
  • 9 Chen X M, Tian G Y. Structural elucidation and antitumor activity of a fructan from Cyathula officinalis Kuan.  Carbohydr Res. 2003;  338 1235-41.
  • 10 Shaw P C, But P PH. Authentication of Panax species and their adulterants by random-primed polymerase chain reaction.  Planta Med. 1995;  61 466-9.
  • 11 Cheng K T, Su C H, Chang H C, Huang J Y. Differentiation of genuine and counterfeits of Cordyceps species using random amplified polymorphic DNA.  Planta Med. 1998;  64 451-3.
  • 12 Cheng H F, Lai B, Chan S C, Chou C P, Yang T H, Huang W H. et al . Molecular differentiation of Atractylodes drugs by PCR-restriction fragment length polymorphism and PCR-selective restriction analysis on the 18S-5.8S rDNA intratranscribed spacer 1 gene.  J Food Drug Anal. 1997;  5 319-27.
  • 13 Cheng K T, Tsay H S, Chen C F, Chou T W. Determination of components in Chinese prescription, yu-ping-feng san, by RAPD analysis.  Planta Med. 1998;  64 563-5.
  • 14 Zhang Y B, Wang J, Wang Z T, But P PH, Shaw P C. DNA microarray for identification of the herb of Dendrobium species from Chinese medicinal formulations.  Planta Med. 2003;  69 1172-4.
  • 15 Lu K T, Lo C F, Chang H C, Lin J H. Identification of Saposhinkoviae Radix in concentrated Chinese medicine preparations by nested PCR and DNA sequencing methods.  J Food Drug Anal. 2005;  13 219-24.
  • 16 Saghai-Maroof M A, Soliman K M, Jorgensen R A, Allare R W. Ribosomal DNA spacer length polymorphism in barly: mendelian inheritance, chromosomal location, and population dynamics.  Proc Natl Acad Sci USA. 1984;  81 8014-8.

Kang-Tsu Lu

Division of Pharmacognosy

Bureau of Food and Drug Analysis

Department of Health

Executive Yuan

Taipei

Taiwan

Republic of China

Phone: +886-2-5653-1085

Fax: +886-2-2653-1244

Email: kangtzu@nlfd.gov.tw